103 related articles for article (PubMed ID: 20357746)
41. Endothelium and the lipid metabolism: the current understanding.
Laroia ST; Ganti AK; Laroia AT; Tendulkar KK
Int J Cardiol; 2003 Mar; 88(1):1-9. PubMed ID: 12659977
[TBL] [Abstract][Full Text] [Related]
42. Cytoprotective action of beraprost sodium against peroxide-induced damage in vascular endothelial cells.
Kainoh M; Nishio S; Nakadate T
Pharmacology; 1992; 45(2):61-70. PubMed ID: 1523215
[TBL] [Abstract][Full Text] [Related]
43. [Research and development of beraprost sodium, a new stable PGI2 analogue].
Nishio S; Nagase H; Kanou K; Aoki S; Kanbayashi Y
Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
Moens AL; Vrints CJ; Claeys MJ; Timmermans JP; Champion HC; Kass DA
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H1971-7. PubMed ID: 18375715
[TBL] [Abstract][Full Text] [Related]
45. Effects of beraprost sodium and prostaglandin E1 on skin blood flow in diabetic rats and normal dogs.
Ueno Y; Yamada N; Koike H; Nishio S
Gen Pharmacol; 1996 Mar; 27(2):333-5. PubMed ID: 8919652
[TBL] [Abstract][Full Text] [Related]
46. Long-term effect of a new oral prostacyclin analogue, beraprost sodium, in isolated peripheral pulmonary artery stenosis in the adult.
Yoshitomi Y; Kojima S; Kuramochi M
J Intern Med; 1999 Aug; 246(2):227-30. PubMed ID: 10447792
[TBL] [Abstract][Full Text] [Related]
47. Ectopic ATP synthase in endothelial cells: a novel cardiovascular therapeutic target.
Fu Y; Zhu Y
Curr Pharm Des; 2010; 16(37):4074-9. PubMed ID: 21247400
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol and endothelial function: A literature review.
Parsamanesh N; Asghari A; Sardari S; Tasbandi A; Jamialahmadi T; Xu S; Sahebkar A
Pharmacol Res; 2021 Aug; 170():105725. PubMed ID: 34119624
[TBL] [Abstract][Full Text] [Related]
49. The Pharmacokinetics of Beraprost Sodium Following Single Oral Administration to Subjects With Impaired Kidney Function.
Shimamura M; Miyakawa J; Doi M; Okada K; Kurumatani H; Mori Y; Oshida K; Nakajo I; Oikawa K; Ushigome F; Miyashita A; Isono M; Miyamoto Y
J Clin Pharmacol; 2017 Apr; 57(4):524-535. PubMed ID: 27681484
[TBL] [Abstract][Full Text] [Related]
50. [Pharmacological profiles and clinical effects of oral sustained release beraprost sodium (Careload LA tablets 60 microg, Berasus LA tablets 60 microg)].
Kurumatani H
Nihon Yakurigaku Zasshi; 2009 Feb; 133(2):101-11. PubMed ID: 19218750
[No Abstract] [Full Text] [Related]
51. The Impact of Antiplatelet Treatment on Endothelial Function.
Androulakis E; Norrington K; Bakogiannis C; Lioudaki E; Siasos G; Tousoulis D
Curr Pharm Des; 2016; 22(29):4512-4518. PubMed ID: 27262335
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males.
Nakajo I; Inoue H; Inaba M; Oikawa K; Katashima M; Sawamoto T; Kurumatani H; Shiramoto M
Clin Drug Investig; 2021 Jun; 41(6):549-555. PubMed ID: 33913081
[TBL] [Abstract][Full Text] [Related]
53. Nitric oxide and arterial disease.
Barbato JE; Tzeng E
J Vasc Surg; 2004 Jul; 40(1):187-93. PubMed ID: 15218485
[TBL] [Abstract][Full Text] [Related]
54. Effects of beraprost sodium on canine cauda equina function and blood flow using a chronic spinal cord compression model.
Konno S; Arai I; Otani K; Olmarker K; Kikuchi S
J Spinal Disord; 2001 Aug; 14(4):336-8. PubMed ID: 11481556
[TBL] [Abstract][Full Text] [Related]
55. Is NO the king? Pathophysiological benefit with uncertain clinical impact.
Simko F
Physiol Res; 2007; 56 Suppl 2():S1-S6. PubMed ID: 17824813
[TBL] [Abstract][Full Text] [Related]
56. Endothelium.
Boulanger CM
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):e26-31. PubMed ID: 27010027
[No Abstract] [Full Text] [Related]
57. Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function.
Suzuki R; Yuchi Y; Saito T; Yasumura Y; Teshima T; Matsumoto H; Koyama H
Animals (Basel); 2022 Aug; 12(16):. PubMed ID: 36009668
[TBL] [Abstract][Full Text] [Related]
58. Cardiovascular effects of coumarins besides their antioxidant activity.
Najmanová I; Doseděl M; Hrdina R; Anzenbacher P; Filipský T; Říha M; Mladěnka P
Curr Top Med Chem; 2015; 15(9):830-49. PubMed ID: 25697565
[TBL] [Abstract][Full Text] [Related]
59. Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases.
Loskove JA; Frishman WH
Am Heart J; 1995 Mar; 129(3):604-13. PubMed ID: 7872193
[TBL] [Abstract][Full Text] [Related]
60. Is prostacyclin an inodilator?
Ricksten SE
Intensive Care Med; 2003 Sep; 29(9):1403-5. PubMed ID: 12904857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
